2 completed, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Dennis Charney: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers Low dose NPY, High dose NPY, Placebo - Mood Disorder, Anxiety Disorders | Phase 2 | Completed | Dennis Charney | 10 | 2010-01-01 | 2017-08-01 |
| Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD) Midazolam, Ketamine - Stress Disorders, Post-Traumatic, PTSD | Phase 2 | Completed | Dennis Charney | 41 | 2009-01-01 | 2018-02-14 |
| Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder ORG 24448, Placebo - Major Depressive Disorder | Phase 2 | Withdrawn | Dennis Charney | 2005-03-01 | 2012-12-11 |
Anxiety Disorders (2) · Consciousness Disorders (1) · Depression (1) · Depressive Disorder, Major (1) · Mood Disorders (1) · Stress Disorders, Post-Traumatic (1)
1-(benzofurazan-5-ylcarbonyl)piperidine (1) · AMPA receptor potentiator HBT1 (1) · Ketamine (1) · Midazolam (1) · Neuropeptide Y (1)
United States (2)
Adriana Feder, MD (1) · Dennis S Charney, MD (1)